Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs58550845 | chr22:50315507 | C/CT | 1.17E-8 | 171 | 25.47 | 27.33 | 3.6 | KM Plot |
PCPG | rs58607194 | chr2:236192541 | C/T | 3.73E-7 | 170 | 27.2 | 24.7 | 3.07 | KM Plot |
PCPG | rs58631773 | chr2:176195103 | T/G | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs58636472 | chr10:29846093 | C/T | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs58660500 | chr3:53086573 | C/T | 7.94E-6 | 173 | 25.08 | 27.27 | 11.78 | KM Plot |
PCPG | rs58681728 | chr11:18141399 | A/G | 3.28E-5 | 177 | 27.2 | 23.82 | 7.97 | KM Plot |
PCPG | rs58716156 | chr1:40519319 | A/G | 0.000336 | 174 | 25.2 | 27.27 | 25.17 | KM Plot |
PCPG | rs587505 | chr13:37505928 | C/G | 0.00034 | 178 | 25.7 | 24.7 | 6.37 | KM Plot |
PCPG | rs58766116 | chr16:90035545 | C/G | 1.26E-8 | 171 | 25.77 | 20.2 | 6.62 | KM Plot |
PCPG | rs588001 | chr3:80677375 | G/A | 0.000137 | 174 | 22.52 | 24.53 | 25.87 | KM Plot |
PCPG | rs58801705 | chr18:74525194 | C/G | 7.46E-9 | 174 | 25.6 | 24.83 | 10.17 | KM Plot |
PCPG | rs58805214 | chr14:74308515 | ATGTTTT/A | 4.2E-6 | 175 | 25.47 | 27.2 | 10.43 | KM Plot |
PCPG | rs58852079 | chr12:56706922 | A/C | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs58876234 | chr22:50258868 | G/A | 0.000157 | 177 | 25.47 | 20.2 | 15.18 | KM Plot |
PCPG | rs58962840 | chr1:40519227 | A/G | 0.000336 | 174 | 25.2 | 27.27 | 25.17 | KM Plot |